Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AZ Health vs Vita Bella

AZ Health
Graded #142

Higher grade

vs+3.799999999999997
Vita Bella
Graded #238

Lower grade

The verdict

AZ Health takes it — 68.7/100 to 64.9/100.

AZ Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AZ Health (AZHM) is an Arizona-based, 100% virtual medical weight-loss clinic offering physician-prescribed compounded semaglutide (from $179/mo) and tirzepatide (from $199/mo), plus NAD+ injections, on…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAZ Health +28
72
44
Dose & formulationAZ Health +20
72
52
Clinical oversightVita Bella +16
75
91
Labs & monitoringVita Bella +25
52
77
FulfillmentVita Bella +11
72
83
Contract termsAZ Health +14
61
47
AZ Health · left barVita Bella · right bar

The numbers

MetricAZ HealthVita Bella
WeighScore68.7/10064.9/100
GradeCC
Scorecard rank#142#238
Semaglutide$179/mo (all doses, compounded)Not disclosed
Tirzepatide$199/mo (all doses, compounded)$159/mo (2.5 mg dose, plus a separate fee, compounded)
CoverageCoverage not published46 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AZ Health

Graded #142 · C

Strengths

  • Transparent flat monthly pricing — semaglutide from $179/mo, tirzepatide from $199/mo, no insurance required
  • Discloses that compounded medications are not FDA-approved and require a prescription
  • FSA/HSA eligible, free discreet shipping, and cancel anytime
  • Ongoing physician check-ins; also offers NAD+ injections

Where it loses points

  • LegitScript certification is self-stated on the site and not independently verifiable
  • Single-page site with no published Terms, Privacy, or HIPAA policy
  • Compounding pharmacy partner not named (states only 'FDA-registered pharmacies')
  • Legal entity not disclosed; availability limited (~half of US states, Arizona-focused)
Vita Bella

Graded #238 · C

Strengths

  • Offers both compounded semaglutide (from $109/mo) and tirzepatide (from $159/mo) at member pricing, with supplies and a B-6 add-in included
  • Genuine LegitScript-certified website (seal #4395819) and a clearly disclosed legal entity, Vita Bella Health, LLC (Nevada)
  • Broad access: care published for 46 states plus Washington, D.C., and HSA cards are accepted
  • Fully remote telehealth with video provider consults and quarterly provider check-ins included in the membership
  • Medications dispensed by US FDA-inspected compounding pharmacies; ondansetron for nausea provided at no extra charge

Where it loses points

  • Advertised $109-$159 medication prices require a separate $129/mo membership plus a one-time $99 consult, pushing true cost to ~$238-288/mo
  • Three-month minimum commitment before it renews month-to-month; no refunds on medications and all sales are final
  • Compounding pharmacy partners are not named anywhere on the site — a transparency gap
  • Compounded semaglutide and tirzepatide are not FDA-approved; only the dispensing pharmacies are described as FDA-inspected
  • Disputes are subject to binding arbitration with a class-action waiver, governed by Nevada law (Las Vegas jurisdiction)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard